These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 4543678)
21. Ag-F: serological and genetic identification of a new locus in the rat governing lymphocyte membrane antigens. DeWitt CW; MCCullough M Transplantation; 1975 Apr; 19(4):310-7. PubMed ID: 1080303 [TBL] [Abstract][Full Text] [Related]
22. Cytotoxic immune cells with specificity for defined soluble antigens. V. Interaction of antibody with the cytotoxic effector cells in immune or non-immune mouse spleen cells. Schirrmacher V; Rubin B; Pross H J Immunol; 1974 Jun; 112(6):2219-26. PubMed ID: 4856907 [No Abstract] [Full Text] [Related]
23. Serological cross-reaction between H-2D and H-2K region antigens. David CS; Shreffler DC; Murphy DB; Klein J Transplant Proc; 1973 Mar; 5(1):287-93. PubMed ID: 4572101 [No Abstract] [Full Text] [Related]
24. Fundamental characteristics of histocompatibility-linked specific immune-response (Ir) genes. McDevitt HO Transplant Proc; 1973 Dec; 5(4):1799-801. PubMed ID: 4590626 [No Abstract] [Full Text] [Related]
25. The immunologic response to xenografts. Recognition of mouse H-2 histocompatibility antigens by the rat. Sachs DH; Winn HJ; Russell PS J Immunol; 1971 Aug; 107(2):481-92. PubMed ID: 4936290 [No Abstract] [Full Text] [Related]
26. Immune response of mice to Thy-1. 1 antigen: genetic control by alleles at the Ir-5 locus loosely linked to the H-2 complex. Zaleski M; Klein J J Immunol; 1974 Oct; 113(4):1170-7. PubMed ID: 4606643 [No Abstract] [Full Text] [Related]
27. Rat alloantibody responses against strong and weak histocompatibility antigens. Miller C; DeWitt C J Immunol; 1972 Nov; 109(5):919-26. PubMed ID: 5079095 [No Abstract] [Full Text] [Related]
28. Cytotoxicity of vivo sensitized lymphocytes on allogeneic third-party fibroblasts differing for various regions of the H-2 complex. Jorgensen PN; Florentz K; Güttler F Transplant Proc; 1974 Mar; 6(1):95-9. PubMed ID: 4817057 [No Abstract] [Full Text] [Related]
29. Cytotoxic immune cells with specificity for defined soluble antigens. 3. Separation from helper cells and from antibody-forming cell precursors. Schirrmacher V; Rubin B; Golstein P; Wigzell H; Andersson B Transplant Proc; 1973 Dec; 5(4):1447-50. PubMed ID: 4544162 [No Abstract] [Full Text] [Related]
30. Specificity of antileukemia sera prepared by immunization with leukemia cells admixed with normal antigen-blocking sera. Smith PJ; Robinson CM; Reif AE Cancer Res; 1974 Jan; 34(1):169-75. PubMed ID: 4129197 [No Abstract] [Full Text] [Related]
31. Genetic analysis and biological properties of products of the third SD (AJ) locus of the HL-A region. Mayr WR; Bernoco D; De Marchi M; Ceppellini R Transplant Proc; 1973 Dec; 5(4):1581-93. PubMed ID: 4130068 [No Abstract] [Full Text] [Related]
32. Reactivity of lymphoid cells from mice humorally tolerant to histocompatibility antigens. Law LW; Appella E; Cohen J; Dean JH Nat New Biol; 1973 Dec; 246(154):174-6. PubMed ID: 4148456 [No Abstract] [Full Text] [Related]
33. Cell-mediated cytotoxicity toward human lymphocytes: comparison between in vivo immunization and in vitro sensitization. Mawas C; Christen Y; Legrand L; Dausset J Transplant Proc; 1973 Dec; 5(4):1691-5. PubMed ID: 4130078 [No Abstract] [Full Text] [Related]
34. Human lymphocyte alloantigen(s) similar to murine Ir region-associated (Ia) antigens. Arbeit RD; Sachs DH; Amos DB; Dickler HB J Immunol; 1975 Oct; 115(4):1173-5. PubMed ID: 51880 [No Abstract] [Full Text] [Related]
35. Alloantiserum-induced inhibition of immune response gene product function. II. Genetic analysis of target antigens. Shevach EM; Green I; Paul WE J Exp Med; 1974 Mar; 139(3):679-95. PubMed ID: 4591175 [TBL] [Abstract][Full Text] [Related]
36. Lymphocyte antigens controlled by the Ir region of the mouse H-2 complex. David CS; Shreffler DC Transplantation; 1974 May; 17(5):462-9. PubMed ID: 4133256 [No Abstract] [Full Text] [Related]
37. The anamnestic response to HL-A and H-2 antigens. Amos DB; Corley RB; Kostyu DD Transplant Proc; 1973 Mar; 5(1):75-7. PubMed ID: 4695956 [No Abstract] [Full Text] [Related]
38. In vitro tests for cell-mediated immunity in thyroid disease. Calder EA Proc R Soc Med; 1974 Jun; 67(6 Pt 1):502-6. PubMed ID: 4546830 [No Abstract] [Full Text] [Related]
39. Mechanism of blocking by hyperimmune serum of lymphocyte-mediated cytolysis of allogeneic tumor cells. Todd RF; Stulting RD; Berke G Cancer Res; 1973 Dec; 33(12):3203-8. PubMed ID: 4760536 [No Abstract] [Full Text] [Related]
40. Cr-releasing cytotoxicity tests: study of parameters influencing their reliability. Gabrilovac J; Boranić M; Radacić M Z Immunitatsforsch Exp Klin Immunol; 1976 Mar; 151(1-2):3-12. PubMed ID: 134526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]